Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt

被引:24
作者
Senzolo, Marco
Patch, David
Cholongitas, Evangelos
Triantos, Christos
Marelli, Laura
Stigliano, Rosa
Dhillon, Amar
Burroughs, Andrew
机构
[1] Royal Free Hosp, Liver Transplantat & Hepatobiliary Unit, London NW3 2QG, England
[2] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
关键词
venoocclusive disease; liver transplantation; transjugular intrahepatic portosystemic shunt;
D O I
10.1097/01.tp.0000225799.76828.ce
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Venoocclusive disease (VOD) is due to hepatic sinusoidal lining injury leading to portal hypertension; its incidence after liver transplantation is about 2%. When severe, it does not respond to medical therapy and has a high mortality; retransplantation is the only therapeutic option. However, there are no detailed data regarding the use of transjugular intrahepatic portosystemic shunt for VOD after liver transplantation. We describe two patients who developed severe VOD after liver transplantation, failed defibrotide therapy, and were treated by transjugular intrahepatic portosystemic shunt (TIPS). The portal hypertension resolved completely and one had full histological recovery. We believe that TIPS should be attempted as it may resolve progressive portal hypertension and the hepatic congestion, while allowing the clinician time for listing for further liver transplantation if the patient fails to respond.
引用
收藏
页码:132 / 135
页数:4
相关论文
共 15 条
[1]   Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation [J].
Azoulay, D ;
Castaing, D ;
Lemoine, A ;
Hargreaves, GM ;
Bismuth, H .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :987-992
[2]  
Baron F, 1997, HAEMATOLOGICA, V82, P718
[3]   VENOOCCLUSIVE DISEASE OF THE LIVER - DEVELOPMENT OF A MODEL FOR PREDICTING FATAL OUTCOME AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI ;
ANDERSON, GL ;
MORI, M ;
HINDS, MS ;
SHULMAN, HM ;
MCDONALD, GB .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1729-1736
[4]   Veno-occlusive disease: cytokines, genetics, and haemostasis [J].
Coppell, JA ;
Brown, SA ;
Perry, DJ .
BLOOD REVIEWS, 2003, 17 (02) :63-70
[5]   Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease) [J].
DeLeve, LD ;
Shulman, HM ;
McDonald, GB .
SEMINARS IN LIVER DISEASE, 2002, 22 (01) :27-41
[6]   Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation [J].
Fried, MW ;
Connaghan, DG ;
Sharma, S ;
Martin, LG ;
Devine, S ;
Holland, K ;
Zuckerman, A ;
Kaufman, S ;
Wingard, J ;
Boyer, TD .
HEPATOLOGY, 1996, 24 (03) :588-591
[7]  
Lee J L, 1999, Biol Blood Marrow Transplant, V5, P306, DOI 10.1016/S1083-8791(99)70006-6
[8]   The hepatologist in the haematologists' camp [J].
Liatsos, C ;
Mehta, AB ;
Potter, M ;
Burroughs, AK .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :567-578
[9]   VENOOCCLUSIVE DISEASE OF THE LIVER AND MULTIORGAN FAILURE AFTER BONE-MARROW TRANSPLANTATION - A COHORT STUDY OF 355 PATIENTS [J].
MCDONALD, GB ;
HINDS, MS ;
FISHER, LD ;
SCHOCH, HG ;
WOLFORD, JL ;
BANAJI, M ;
HARDIN, BJ ;
SHULMAN, HM ;
CLIFT, RA .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :255-267
[10]   Defibrotide for the treatment of veno-occlusive disease after liver transplantation [J].
Mor, E ;
Pappo, O ;
Bar-Nathan, N ;
Shaharabani, E ;
Shapira, Z ;
Tur-Kaspa, R ;
Ben-Ari, Z .
TRANSPLANTATION, 2001, 72 (07) :1237-1240